BRPI0415388A - moderação do efeito das endotoxinas - Google Patents

moderação do efeito das endotoxinas

Info

Publication number
BRPI0415388A
BRPI0415388A BRPI0415388-0A BRPI0415388A BRPI0415388A BR PI0415388 A BRPI0415388 A BR PI0415388A BR PI0415388 A BRPI0415388 A BR PI0415388A BR PI0415388 A BRPI0415388 A BR PI0415388A
Authority
BR
Brazil
Prior art keywords
effects
moderation
endotoxin effect
oral composition
endotoxin
Prior art date
Application number
BRPI0415388-0A
Other languages
English (en)
Inventor
Irene Corthesy-Theulaz
Grigorios Fotopoulos
Gabriela Bergonzelli
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0415388A publication Critical patent/BRPI0415388A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"MODERAçãO DO EFEITO DAS ENDOTOXINAS". A presente invenção refere-se ao uso de uma composição oral compreendendo extrato de levedura, na fabricação de uma composição oral para tratar os efeitos da infecção por bactérias patogênicas, tais como Clostridium difficile. Tais efeitos podem incluir a deficiência da integridade das células epiteliais do intestino e a diarréia, bem como outros efeitos mediados pela COX-2.
BRPI0415388-0A 2003-10-13 2004-10-13 moderação do efeito das endotoxinas BRPI0415388A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03023015 2003-10-13
PCT/EP2004/011470 WO2005039609A2 (en) 2003-10-13 2004-10-13 Moderating the effect of endotoxins

Publications (1)

Publication Number Publication Date
BRPI0415388A true BRPI0415388A (pt) 2006-12-12

Family

ID=34354432

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415388-0A BRPI0415388A (pt) 2003-10-13 2004-10-13 moderação do efeito das endotoxinas

Country Status (10)

Country Link
US (2) US20060292171A1 (pt)
EP (1) EP1689417A2 (pt)
JP (1) JP2007508342A (pt)
CN (1) CN1889966A (pt)
AR (1) AR046107A1 (pt)
BR (1) BRPI0415388A (pt)
CA (1) CA2542452A1 (pt)
IL (1) IL175080A0 (pt)
TW (1) TW200520767A (pt)
WO (1) WO2005039609A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2328149T5 (es) 2003-10-13 2013-07-12 Nestec S.A. Moderación del efecto de las endotoxinas
EP3685681A1 (en) * 2019-01-23 2020-07-29 Lesaffre et Compagnie A yeast product, and a composition comprising it, for use as a prebiotic agent
CN113729228A (zh) * 2020-05-29 2021-12-03 安琪纽特股份有限公司 用于预防或改善腹泻的组合物及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US177534A (en) * 1876-05-16 Improvement in meat-extracts
US4595590A (en) * 1984-01-17 1986-06-17 Laboratoires Biocodex Method for preventing or treating pseudo-membranous colitis
EP0195870B1 (fr) * 1985-03-22 1990-01-31 Laboratoires BIOCODEX Utilisation de levures saccharomyces pour la fabrication d'un médicament contre l'amibiase
JPS61236727A (ja) * 1985-04-12 1986-10-22 Advance Res & Dev Co Ltd 抗う蝕乃至抗菌周症剤
JP2805490B2 (ja) * 1989-02-07 1998-09-30 雪印乳業株式会社 細菌毒素中和剤
FR2711528B1 (fr) * 1993-10-25 1996-02-09 Biocodex Lab Utilisation de levures Saccharomyces pour la fabrication d'un médicament contre la cryptosporidiose.
US5550106A (en) * 1994-03-04 1996-08-27 Bristol-Myers Squibb Company Low buffer nutritional composition
JP2001008636A (ja) * 1999-06-30 2001-01-16 Tanabe Seiyaku Co Ltd 感染症防止用飼料組成物
JP2001055338A (ja) * 1999-08-13 2001-02-27 Kirin Brewery Co Ltd 酵母細胞壁画分からなる薬理用組成物
JP3307627B2 (ja) * 2000-02-09 2002-07-24 オク タイン 酵母ジゴサッカロマイシスロキシイ（Ｚｙｇｏｓａｃｃｈａｒｏｍｙｃｅｓｒｏｕｘｉｉ）からサイトカラシン（Ｃｙｔｏｃｈａｌａｓｉｎ）様物質群を製造する方法。
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
JP2002080351A (ja) * 2000-09-07 2002-03-19 Natl Fedelation Of Agricult Coop Assoc 免疫増強剤
FI114895B (fi) * 2001-05-14 2005-01-31 Suomen Rehu Oy Ravinnon lisäaine
ES2311729T5 (es) * 2002-06-28 2013-02-14 Biosearch S.A. Cepas probióticas, un procedimiento para la selección de ellas, composiciones de las mismas y su uso
ES2328149T5 (es) * 2003-10-13 2013-07-12 Nestec S.A. Moderación del efecto de las endotoxinas

Also Published As

Publication number Publication date
EP1689417A2 (en) 2006-08-16
JP2007508342A (ja) 2007-04-05
WO2005039609A3 (en) 2005-08-11
IL175080A0 (en) 2008-04-13
WO2005039609A2 (en) 2005-05-06
US20100028316A1 (en) 2010-02-04
TW200520767A (en) 2005-07-01
AR046107A1 (es) 2005-11-23
CA2542452A1 (en) 2005-05-06
US20060292171A1 (en) 2006-12-28
CN1889966A (zh) 2007-01-03

Similar Documents

Publication Publication Date Title
Chen et al. Digestion under saliva, simulated gastric and small intestinal conditions and fermentation in vitro of polysaccharides from the flowers of Camellia sinensis induced by human gut microbiota
BRPI0801858A2 (pt) uso de pelo menos um meio de cultura celular condicionado ou de seu extrato e composiÇço cosmÉtica ou dermatolàgica
BRPI0820177B8 (pt) métodos para produzir um extrato de proteína a partir de células fixadas ou não-fixadas
TW200605796A (en) Processes for preparing plant matter extracts and pet food compositions
BR112013017021A2 (pt) composição nutricional compreendendo fibra e probióticos para reduzir os sintomas intestinais realacionados ao estresse
BRPI0611535A8 (pt) Métodos para processar células de microorganismos e células de levedura, composição, suplemento alimentar, produto farmacêutico, cosmético ou produto nutracêutico e ração animal
BRPI0517514A (pt) vesìculas bacterianas imunogênicas com proteìnas da membrana externa
Chia et al. Can algae contribute to the war with Covid-19?
BRPI0511441B8 (pt) composições contendo uma partícula de glucano oca ou partícula de parede celular encapsulando um componente de terpeno, métodos de fabricação e uso das mesmas
BRPI0412138A (pt) anticorpo, hibridoma, método de produzir um anticorpo, composição farmacêutica, métodos de potencializar a atividade de célula, de detectar a presença de células nk e de purificar de uma amostra células nk, e, composição
BR112012032979B8 (pt) Composição para limpeza da pele límpida, de baixa irritação, e com ph relativamente baixo e método de limpeza da pele
BR112021019349A2 (pt) Células-tronco preparadas altamente funcionais
BRPI0519923A2 (pt) polipeptìdeo, seqüência de dna, vetor de dna, anticorpo, bactéria, método para produzir lps parcialmente 3-o-desacilado, composição, usos da bactéria, e de lps de bordetella isolado compreendendo lps pelo menos parcialmente 3-o-desacilado, vacina, e , método in vitro para a desacilação de lps gram-negativo ou de composições compreendendo lps gram-negativo
BR112012020628A2 (pt) fotoiniciador de éter polialquílico, uso de um fotoiniciador de éter polialquílico, método para curar uma composição de matriz, e, composição de matriz
AR033574A1 (es) Una cepa bacteriana del grupo de las bacterias lacticas capaces de reducir la tendencia de un individuo a desarrollar reacciones alergicas, las composiciones alimenticias y farmaceuticas que la contienen y las vacunas que la contienen
AR068419A1 (es) Cepas de mycoplasma atenuadas vivas
AR046123A1 (es) Aislamiento de celulas simil-celulas madre, uso de las mismas
Basak et al. Evaluation of cytotoxicity and gelatinases activity in 3T3 fibroblast cell by root repair materials
BR112022010174A2 (pt) Composições para aperfeiçoamento do desempenho atlético e métodos de uso das mesmas
BRPI0415388A (pt) moderação do efeito das endotoxinas
BR0214860A (pt) Construto ou tecido celular, processo de preparação de um construto celular, utilização de um construto, método de preparação de um implante com ajuda de um construto, kit para a preparação de um construto, composição farmacêutica e implante
ATE541855T1 (de) Weitere kristalline formen von rostafuroxin
BRPI0415385A (pt) moderação do efeito de endotoxinas
Tanti et al. Assessment of antimicrobial and antioxidant activities of Dendrocnide sinuata (Blume) Chew leaves–a medicinal plant used by ethnic communities of north east India
BR112022003438A2 (pt) Uso de cores naturais encapsuladas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.

B15K Others concerning applications: alteration of classification

Ipc: A61K 36/06 (2006.01), A61P 1/00 (2006.01)